Temporal Trends, Predictors, and Outcomes of In-Hospital Gastrointestinal Bleeding Associated With Percutaneous Coronary Intervention

Nileshkumar J. Patel, Dhaval Pau, Nikhil Nalluri, Parth Bhatt, Badal Thakkar, Ritesh Kanotra, Kanishk Agnihotri, Nitesh Ainani, Nilay Patel, Nish Patel, Sapna Shah, Sabeeda Kadavath, Shilpkumar Arora, Azfar Sheikh, Apurva O. Badheka, James Lafferty, Carlos E Alfonso, Mauricio G Cohen

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

Since the introduction of new antiplatelet and anticoagulant agents in the last decade, large-scale data studying gastrointestinal bleeding (GIB) in patients undergoing percutaneous coronary intervention (PCI) are lacking. Using the Nationwide Inpatient Sample, we identified all hospitalizations from 2006 to 2012 that required PCI. Temporal trends in the incidence and multivariate predictors of GIB associated with PCI were analyzed. A total of 4,376,950 patients underwent PCI in the United States during the study period. The incidence of GIB was 1.1%. Mortality rate in the GIB group was significantly higher (9.71% vs 1.1%, p <0.0001). Although the incidence of GIB remained stable during the study period (0.97% in 2006 to 1.19% in 2012), in-hospital mortality rate increased significantly from 7.9% in 2006 to 10.78% in 2012, with a peak of 12% in 2010. The GIB group had a longer median length of stay (5.80 vs 1.57 days) and an increased median cost of hospitalization ($26,564 vs $16,879). The predictors of GIB included cardiovascular co-morbidities such as acute myocardial infarction, cardiogenic shock, atrial fibrillation, congestive heart failure, valvular heart diseases, and a history of transient ischemic attack/stroke. Gastrointestinal co-morbidities including diverticulosis, esophageal cancer, stomach cancer, small intestine cancer, large intestine cancer, rectosigmoid cancer, gastrointestinal ulcer, and liver disease were predictors of GIB. Interestingly, a lower risk of GIB was associated with obese patients and patients with private insurance. A higher risk of GIB was noted in urgent versus elective admissions and weekend versus weekday admissions. In conclusion, the incidence of GIB in patients who underwent PCI remained stable from 2006 to 2012; however, the in-hospital mortality increased significantly. Identifying patients at higher risk for GIB is critically important to develop preventive strategies to reduce morbidity and mortality.

Original languageEnglish (US)
Pages (from-to)1150-1157
Number of pages8
JournalAmerican Journal of Cardiology
Volume118
Issue number8
DOIs
StatePublished - Oct 15 2016

Fingerprint

Percutaneous Coronary Intervention
Hemorrhage
Intestinal Neoplasms
Incidence
Hospital Mortality
Morbidity
Stomach Neoplasms
Mortality
Hospitalization
Heart Valve Diseases
Cardiogenic Shock
Gastrointestinal Diseases
Platelet Aggregation Inhibitors
Large Intestine
Diverticulum
Transient Ischemic Attack
Esophageal Neoplasms
Insurance
Anticoagulants
Atrial Fibrillation

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Temporal Trends, Predictors, and Outcomes of In-Hospital Gastrointestinal Bleeding Associated With Percutaneous Coronary Intervention. / Patel, Nileshkumar J.; Pau, Dhaval; Nalluri, Nikhil; Bhatt, Parth; Thakkar, Badal; Kanotra, Ritesh; Agnihotri, Kanishk; Ainani, Nitesh; Patel, Nilay; Patel, Nish; Shah, Sapna; Kadavath, Sabeeda; Arora, Shilpkumar; Sheikh, Azfar; Badheka, Apurva O.; Lafferty, James; Alfonso, Carlos E; Cohen, Mauricio G.

In: American Journal of Cardiology, Vol. 118, No. 8, 15.10.2016, p. 1150-1157.

Research output: Contribution to journalArticle

Patel, NJ, Pau, D, Nalluri, N, Bhatt, P, Thakkar, B, Kanotra, R, Agnihotri, K, Ainani, N, Patel, N, Patel, N, Shah, S, Kadavath, S, Arora, S, Sheikh, A, Badheka, AO, Lafferty, J, Alfonso, CE & Cohen, MG 2016, 'Temporal Trends, Predictors, and Outcomes of In-Hospital Gastrointestinal Bleeding Associated With Percutaneous Coronary Intervention', American Journal of Cardiology, vol. 118, no. 8, pp. 1150-1157. https://doi.org/10.1016/j.amjcard.2016.07.025
Patel, Nileshkumar J. ; Pau, Dhaval ; Nalluri, Nikhil ; Bhatt, Parth ; Thakkar, Badal ; Kanotra, Ritesh ; Agnihotri, Kanishk ; Ainani, Nitesh ; Patel, Nilay ; Patel, Nish ; Shah, Sapna ; Kadavath, Sabeeda ; Arora, Shilpkumar ; Sheikh, Azfar ; Badheka, Apurva O. ; Lafferty, James ; Alfonso, Carlos E ; Cohen, Mauricio G. / Temporal Trends, Predictors, and Outcomes of In-Hospital Gastrointestinal Bleeding Associated With Percutaneous Coronary Intervention. In: American Journal of Cardiology. 2016 ; Vol. 118, No. 8. pp. 1150-1157.
@article{d17cc767d2294672b50226899288dfb1,
title = "Temporal Trends, Predictors, and Outcomes of In-Hospital Gastrointestinal Bleeding Associated With Percutaneous Coronary Intervention",
abstract = "Since the introduction of new antiplatelet and anticoagulant agents in the last decade, large-scale data studying gastrointestinal bleeding (GIB) in patients undergoing percutaneous coronary intervention (PCI) are lacking. Using the Nationwide Inpatient Sample, we identified all hospitalizations from 2006 to 2012 that required PCI. Temporal trends in the incidence and multivariate predictors of GIB associated with PCI were analyzed. A total of 4,376,950 patients underwent PCI in the United States during the study period. The incidence of GIB was 1.1{\%}. Mortality rate in the GIB group was significantly higher (9.71{\%} vs 1.1{\%}, p <0.0001). Although the incidence of GIB remained stable during the study period (0.97{\%} in 2006 to 1.19{\%} in 2012), in-hospital mortality rate increased significantly from 7.9{\%} in 2006 to 10.78{\%} in 2012, with a peak of 12{\%} in 2010. The GIB group had a longer median length of stay (5.80 vs 1.57 days) and an increased median cost of hospitalization ($26,564 vs $16,879). The predictors of GIB included cardiovascular co-morbidities such as acute myocardial infarction, cardiogenic shock, atrial fibrillation, congestive heart failure, valvular heart diseases, and a history of transient ischemic attack/stroke. Gastrointestinal co-morbidities including diverticulosis, esophageal cancer, stomach cancer, small intestine cancer, large intestine cancer, rectosigmoid cancer, gastrointestinal ulcer, and liver disease were predictors of GIB. Interestingly, a lower risk of GIB was associated with obese patients and patients with private insurance. A higher risk of GIB was noted in urgent versus elective admissions and weekend versus weekday admissions. In conclusion, the incidence of GIB in patients who underwent PCI remained stable from 2006 to 2012; however, the in-hospital mortality increased significantly. Identifying patients at higher risk for GIB is critically important to develop preventive strategies to reduce morbidity and mortality.",
author = "Patel, {Nileshkumar J.} and Dhaval Pau and Nikhil Nalluri and Parth Bhatt and Badal Thakkar and Ritesh Kanotra and Kanishk Agnihotri and Nitesh Ainani and Nilay Patel and Nish Patel and Sapna Shah and Sabeeda Kadavath and Shilpkumar Arora and Azfar Sheikh and Badheka, {Apurva O.} and James Lafferty and Alfonso, {Carlos E} and Cohen, {Mauricio G}",
year = "2016",
month = "10",
day = "15",
doi = "10.1016/j.amjcard.2016.07.025",
language = "English (US)",
volume = "118",
pages = "1150--1157",
journal = "American Journal of Cardiology",
issn = "0002-9149",
publisher = "Elsevier Inc.",
number = "8",

}

TY - JOUR

T1 - Temporal Trends, Predictors, and Outcomes of In-Hospital Gastrointestinal Bleeding Associated With Percutaneous Coronary Intervention

AU - Patel, Nileshkumar J.

AU - Pau, Dhaval

AU - Nalluri, Nikhil

AU - Bhatt, Parth

AU - Thakkar, Badal

AU - Kanotra, Ritesh

AU - Agnihotri, Kanishk

AU - Ainani, Nitesh

AU - Patel, Nilay

AU - Patel, Nish

AU - Shah, Sapna

AU - Kadavath, Sabeeda

AU - Arora, Shilpkumar

AU - Sheikh, Azfar

AU - Badheka, Apurva O.

AU - Lafferty, James

AU - Alfonso, Carlos E

AU - Cohen, Mauricio G

PY - 2016/10/15

Y1 - 2016/10/15

N2 - Since the introduction of new antiplatelet and anticoagulant agents in the last decade, large-scale data studying gastrointestinal bleeding (GIB) in patients undergoing percutaneous coronary intervention (PCI) are lacking. Using the Nationwide Inpatient Sample, we identified all hospitalizations from 2006 to 2012 that required PCI. Temporal trends in the incidence and multivariate predictors of GIB associated with PCI were analyzed. A total of 4,376,950 patients underwent PCI in the United States during the study period. The incidence of GIB was 1.1%. Mortality rate in the GIB group was significantly higher (9.71% vs 1.1%, p <0.0001). Although the incidence of GIB remained stable during the study period (0.97% in 2006 to 1.19% in 2012), in-hospital mortality rate increased significantly from 7.9% in 2006 to 10.78% in 2012, with a peak of 12% in 2010. The GIB group had a longer median length of stay (5.80 vs 1.57 days) and an increased median cost of hospitalization ($26,564 vs $16,879). The predictors of GIB included cardiovascular co-morbidities such as acute myocardial infarction, cardiogenic shock, atrial fibrillation, congestive heart failure, valvular heart diseases, and a history of transient ischemic attack/stroke. Gastrointestinal co-morbidities including diverticulosis, esophageal cancer, stomach cancer, small intestine cancer, large intestine cancer, rectosigmoid cancer, gastrointestinal ulcer, and liver disease were predictors of GIB. Interestingly, a lower risk of GIB was associated with obese patients and patients with private insurance. A higher risk of GIB was noted in urgent versus elective admissions and weekend versus weekday admissions. In conclusion, the incidence of GIB in patients who underwent PCI remained stable from 2006 to 2012; however, the in-hospital mortality increased significantly. Identifying patients at higher risk for GIB is critically important to develop preventive strategies to reduce morbidity and mortality.

AB - Since the introduction of new antiplatelet and anticoagulant agents in the last decade, large-scale data studying gastrointestinal bleeding (GIB) in patients undergoing percutaneous coronary intervention (PCI) are lacking. Using the Nationwide Inpatient Sample, we identified all hospitalizations from 2006 to 2012 that required PCI. Temporal trends in the incidence and multivariate predictors of GIB associated with PCI were analyzed. A total of 4,376,950 patients underwent PCI in the United States during the study period. The incidence of GIB was 1.1%. Mortality rate in the GIB group was significantly higher (9.71% vs 1.1%, p <0.0001). Although the incidence of GIB remained stable during the study period (0.97% in 2006 to 1.19% in 2012), in-hospital mortality rate increased significantly from 7.9% in 2006 to 10.78% in 2012, with a peak of 12% in 2010. The GIB group had a longer median length of stay (5.80 vs 1.57 days) and an increased median cost of hospitalization ($26,564 vs $16,879). The predictors of GIB included cardiovascular co-morbidities such as acute myocardial infarction, cardiogenic shock, atrial fibrillation, congestive heart failure, valvular heart diseases, and a history of transient ischemic attack/stroke. Gastrointestinal co-morbidities including diverticulosis, esophageal cancer, stomach cancer, small intestine cancer, large intestine cancer, rectosigmoid cancer, gastrointestinal ulcer, and liver disease were predictors of GIB. Interestingly, a lower risk of GIB was associated with obese patients and patients with private insurance. A higher risk of GIB was noted in urgent versus elective admissions and weekend versus weekday admissions. In conclusion, the incidence of GIB in patients who underwent PCI remained stable from 2006 to 2012; however, the in-hospital mortality increased significantly. Identifying patients at higher risk for GIB is critically important to develop preventive strategies to reduce morbidity and mortality.

UR - http://www.scopus.com/inward/record.url?scp=84994795007&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84994795007&partnerID=8YFLogxK

U2 - 10.1016/j.amjcard.2016.07.025

DO - 10.1016/j.amjcard.2016.07.025

M3 - Article

C2 - 27642112

AN - SCOPUS:84994795007

VL - 118

SP - 1150

EP - 1157

JO - American Journal of Cardiology

JF - American Journal of Cardiology

SN - 0002-9149

IS - 8

ER -